DC
PGNX

Deere & Company’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Deere & Company’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-75,116
Closed -$560K – 1095
2015
Q2 		$560K Buy
+75,116
New +$454K 0.03% 598
2013
Q3 		– Sell
-120,279
Closed -$536K – 1097
2013
Q2 		$536K Buy
+120,279
New +$540K 0.03% 627

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deere & Company's PGNX Position: Q3 2015 in Review

Deere & Company sold out of Progenics Pharmaceuticals Inc (PGNX) in Q3 2015, closing a stake of 75,116 shares — an estimated $560K sold.

Deere & Company first reported a position in PGNX in Q2 2013 and held it in 2 quarters. The position peaked at $560K in Q2 2015. 133 funds tracked by Wall St. Rank hold PGNX as of Q3 2015.

  • Deere & Company reported no remaining Progenics Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • Deere & Company sold 75,116 Progenics Pharmaceuticals Inc shares in Q3 2015, an estimated $560K.
  • Deere & Company first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Deere & Company's Progenics Pharmaceuticals Inc position peaked at $560K in Q2 2015.
  • 133 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q3 2015.

Based on Deere & Company's 13F filing for Q3 2015, filed 12 Nov 2015.